Tokumoto, Shoichi
Nishiyama, Masahiro
Yamaguchi, Hiroshi
Tomioka, Kazumi
Ishida, Yusuke
Toyoshima, Daisaku
Kurosawa, Hiroshi
Nozu, Kandai
Maruyama, Azusa
Tanaka, Ryojiro
Iijima, Kazumoto
Nagase, Hiroaki
Article History
Received: 19 October 2021
Accepted: 28 February 2022
First Online: 5 March 2022
Declarations
:
: The study and all methods were performed in accordance with the Declaration of Helsinki. The study design was approved by the ethics committee of Hyogo Prefectural Kobe Children’s Hospital and the Kobe University Graduate School of Medicine (Medical Research Ethics Committee of Kobe University Graduate School of Medicine, No. 170019). The requirement of informed consent was waived because of the retrospective study design, which was approved by the Medical Research Ethics Committee of Kobe University Graduate School of Medicine.
: Not applicable.
: The authors have no financial relationships relevant to this article to disclose. Potential conflicts of interest: Kazumoto Iijima has received grants from Eisai Co., Ltd, and consulting fees from Takeda P Pharma Co., Ltd.; Kandai Nozu has received consulting fees from Eisai Co., Ltd, and lecture fees from Sumitomo Dainippon Pharma Co., Ltd. There is no potential conflict of interest by the rest of the authors.